Find a research study

Learn about research that is happening in the UK today. Participating in research can help us understand more about PF and find better, more effective treatments. You may be able to take part – search for open studies.

This page is under development. We welcome your feedback! Please email research@actionpf.org.

Are you a researcher currently recruiting participants in the UK? If you would like your study included on this page, please complete this online form.

Show filter options
Reset filters
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis
Healthy volunteers
Northern Ireland
Wales
Scotland
England
Further explanation
Open-label extension

Some studies offer an extension phase of research, where people continue to receive the new drug or therapy after the initial trial has finished. The extension phase is often ‘open-label’, which means that you will know that you are receiving the active treatment .

Further explanation
Can continue on antifibrotics

Within studies, there are different requirements that someone must meet, to be able to take part. Some studies recruit people who are taking antifibrotic medications, including nintedanib or pirfenidone. However, in other studies people taking part must not be taking antifibrotic medication.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
0
 result/s
, filtered by:

BTS Interstitial Lung Disease Registry

Upcoming
Open
Closed
Results available
Ongoing
participation
Other research
Remote
Can continue on antifibrotics
England
Scotland
Northern Ireland
Wales
Open
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis

Can a nutritional support intervention help people who are malnourished?

Upcoming
Open
Closed
Results available
3 months
participation
Other research
Hybrid
Can continue on antifibrotics
England
Open
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis

How does PF affect sexual function?

Upcoming
Open
Closed
Results available
10 minute Survey
participation
Survey
Remote
England
Scotland
Wales
Northern Ireland
Closed
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis

Fibroneer-ILD: Can the drug, BI 1015550, slow lung function decline?

Upcoming
Open
Closed
Results available
Up to 2.5 years
participation
Taking a drug
Hospital visits
Can continue on antifibrotics
England
Scotland
Closed
Other forms of pulmonary fibrosis

REMOTE-ILD: Can a new mobile app help for home monitoring?

Upcoming
Open
Closed
Results available
12 months
participation
Other research
Remote
Can continue on antifibrotics
England
Open
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis

Can orvepitant reduce IPF cough?

Upcoming
Open
Closed
Results available
17 weeks
participation
Taking a drug
Hybrid
Can continue on antifibrotics
England
Scotland
Northern Ireland
Closed
Idiopathic Pulmonary Fibrosis (IPF)

Zephyrus II: Is Pamrevlumab safe and effective for people with IPF?

Upcoming
Open
Closed
Results available
Up to 48 weeks
participation
Taking a drug
Hospital visits
Open-label extension
England
Results available
Idiopathic Pulmonary Fibrosis (IPF)

Can financial incentive increase pulmonary rehabilitation participation?

Upcoming
Open
Closed
Results available
participation
Other research
Remote
Can continue on antifibrotics
England
Scotland
Wales
Northern Ireland
Open
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis

European IPF Registry and Biobank

Upcoming
Open
Closed
Results available
Up to 5 years
participation
Other research
Hospital visits
Can continue on antifibrotics
England
Open
Idiopathic Pulmonary Fibrosis (IPF)

Fibroneer-IPF: Can the drug, BI 1015550, slow lung function decline?

Upcoming
Open
Closed
Results available
Up to 2.5 years
participation
Taking a drug
Hospital visits
Can continue on antifibrotics
England
Scotland
Closed
Idiopathic Pulmonary Fibrosis (IPF)

Can morphine reduce IPF cough?

Upcoming
Open
Closed
Results available
7 weeks
participation
Taking a drug
Hybrid
Open-label extension
England
Results available
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis

Can lansoprazole slow IPF disease progression?

Upcoming
Open
Closed
Results available
1 year
participation
Taking a drug
Hybrid
Can continue on antifibrotics
England
Open
Idiopathic Pulmonary Fibrosis (IPF)

How does the body respond to a new drug, LTI-03?

Upcoming
Open
Closed
Results available
21 days
participation
Taking a drug
Hospital visits
England
Scotland
Open
Idiopathic Pulmonary Fibrosis (IPF)

Can antibody testing help to identify risk for clinical vulnerability to COVID-19?

Upcoming
Open
Closed
Results available
Until Spring 2025
participation
Other research
Hybrid
Can continue on antifibrotics
England
Scotland
Wales
Northern Ireland
Open
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis

British Pigeon Fanciers Genetics of ILD Register

Upcoming
Open
Closed
Results available
Up to 5 years
participation
Other research
Hospital visits
Can continue on antifibrotics
Scotland
England
Open
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis

Can inhaled pirfenidone help people with IPF?

Upcoming
Open
Closed
Results available
72 weeks
participation
Taking a drug
Hospital visits
England
Closed
Idiopathic Pulmonary Fibrosis (IPF)
No match for these filter settings

APF does not endorse or recommend any specific study. All responsibility for the study remains with the sponsors and investigators. You may still be able to take part if studies aren't local to you. Every effort is made to keep these details up to date. If you are aware of any inaccuracies, please email research@actionpf.org. You may also request for a study to be added.